1.Identification of Immunodominant B-cell Epitope Regions of Reticulocyte Binding Proteins in Plasmodium vivax by Protein Microarray Based Immunoscreening.
Jin Hee HAN ; Jian LI ; Bo WANG ; Seong Kyun LEE ; Myat Htut NYUNT ; Sunghun NA ; Jeong Hyun PARK ; Eun Taek HAN
The Korean Journal of Parasitology 2015;53(4):403-411
Plasmodium falciparum can invade all stages of red blood cells, while Plasmodium vivax can invade only reticulocytes. Although many P. vivax proteins have been discovered, their functions are largely unknown. Among them, P. vivax reticulocyte binding proteins (PvRBP1 and PvRBP2) recognize and bind to reticulocytes. Both proteins possess a C-terminal hydrophobic transmembrane domain, which drives adhesion to reticulocytes. PvRBP1 and PvRBP2 are large (> 326 kDa), which hinders identification of the functional domains. In this study, the complete genome information of the P. vivax RBP family was thoroughly analyzed using a prediction server with bioinformatics data to predict B-cell epitope domains. Eleven pvrbp family genes that included 2 pseudogenes and 9 full or partial length genes were selected and used to express recombinant proteins in a wheat germ cell-free system. The expressed proteins were used to evaluate the humoral immune response with vivax malaria patients and healthy individual serum samples by protein microarray. The recombinant fragments of 9 PvRBP proteins were successfully expressed; the soluble proteins ranged in molecular weight from 16 to 34 kDa. Evaluation of the humoral immune response to each recombinant PvRBP protein indicated a high antigenicity, with 38-88% sensitivity and 100% specificity. Of them, N-terminal parts of PvRBP2c (PVX_090325-1) and PvRBP2 like partial A (PVX_090330-1) elicited high antigenicity. In addition, the PvRBP2-like homologue B (PVX_116930) fragment was newly identified as high antigenicity and may be exploited as a potential antigenic candidate among the PvRBP family. The functional activity of the PvRBP family on merozoite invasion remains unknown.
Epitopes, B-Lymphocyte/*chemistry/genetics/*immunology
;
Female
;
Humans
;
Immunodominant Epitopes/chemistry/genetics/*immunology
;
Malaria, Vivax/immunology/*parasitology
;
Middle Aged
;
Plasmodium vivax/chemistry/genetics/*immunology
;
Protein Structure, Tertiary
;
Protozoan Proteins/chemistry/genetics/*immunology
;
Reticulocytes/*parasitology
2.ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas.
Sera KIM ; Hye Jin AHN ; Tong Soo KIM ; Ho Woo NAM
The Korean Journal of Parasitology 2003;41(4):203-207
An ELISA was developed for the diagnosis of vivax malaria using multiple stage-specific recombinant antigens of Plasmodium vivax. The DNA from the whole blood of a malaria patient was used as template to amplify the coding regions for the antigenic domains of circumsporozoite protein (CSP-1), merozoite surface protein (MSP-1), apical merozoite antigen (AMA-1), serine repeat antigen (SERA), and exported antigen (EXP-1). Each amplified DNA fragment was inserted into pQE30 plasmid to induce the expression of His-tagged protein in Escherichia coli (M15 strain) by IPTG. His-tagged proteins were purified by Ni-NTA metal-affinity chromatography and used as antigens for ELISA with patient sera that were confirmed previously by blood smear examinations. When applied to patient sera, 122 (80.3%) out of 152 vivax malaria cases reacted to at least one antigen, while no reactions were observed with 128 uninfected serum samples. We applied this ELISA to the screening of 3, 262 civilian residents in endemic regions near the DMZ, which resulted in 236 positively detected (7.2%) cases. This method can be applied to serological diagnosis and mass screening in endemic regions, or can be used as a safety test for transfusion blood in endemic areas.
Animals
;
Antibodies, Protozoan/*blood
;
Antigens, Protozoan/genetics/*immunology
;
*Endemic Diseases
;
Enzyme-Linked Immunosorbent Assay/methods
;
Humans
;
Life Cycle Stages
;
Malaria, Vivax/*diagnosis/epidemiology/parasitology
;
Mass Screening
;
Plasmodium vivax/*growth & development/immunology
;
Recombinant Proteins/*immunology
;
Serologic Tests
3.CD8+ T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging Korean Plasmodium vivax.
Hyo Jin KIM ; Bong Kwang JUNG ; Jin Joo LEE ; Kyoung Ho PYO ; Tae Yun KIM ; Byung il CHOI ; Tae Woo KIM ; Hajime HISAEDA ; Kunisuke HIMENO ; Eun Hee SHIN ; Jong Yil CHAI
The Korean Journal of Parasitology 2011;49(1):85-90
Relatively little has been studied on the AMA-1 vaccine against Plasmodium vivax and on the plasmid DNA vaccine encoding P. vivax AMA-1 (PvAMA-1). In the present study, a plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax has been constructed and a preliminary study was done on its cellular immunogenicity to recipient BALB/c mice. The PvAMA-1 gene was cloned and expressed in the plasmid vector UBpcAMA-1, and a protein band of approximately 56.8 kDa was obtained from the transfected COS7 cells. BALB/c mice were immunized intramuscularly or using a gene gun 4 times with the vaccine, and the proportions of splenic T-cell subsets were examined by fluorocytometry at week 2 after the last injection. The spleen cells from intramuscularly injected mice revealed no significant changes in the proportions of CD8+ T-cells and CD4+ T-cells. However, in mice immunized using a gene gun, significantly higher (P<0.05) proportions of CD8+ cells were observed compared to UB vector-injected control mice. The results indicated that cellular immunogenicity of the plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax was weak when it was injected intramuscularly; however, a promising effect was observed using the gene gun injection technique.
Animals
;
Antigens, Protozoan/administration & dosage/genetics/*immunology
;
CD8-Positive T-Lymphocytes/*immunology
;
COS Cells
;
Cercopithecus aethiops
;
Humans
;
Lymphocyte Activation
;
Malaria, Vivax/*immunology/parasitology
;
Membrane Proteins/administration & dosage/genetics/*immunology
;
Mice
;
Mice, Inbred BALB C
;
Plasmodium vivax/genetics/*immunology
;
Protozoan Proteins/administration & dosage/genetics/*immunology
;
Protozoan Vaccines/administration & dosage/genetics/*immunology
;
Vaccines, DNA/administration & dosage/genetics/*immunology
4.Probability of Antibody Formation against Circumsporozoite Protein of Plasmodium vivax among Korean Malaria Patients.
Ho Woo NAM ; Kyoung Ju SONG ; Hye Jin AHN ; Zhaoshou YANG ; Chom Kyu CHONG ; Pyo Yun CHO ; Seong Kyu AHN ; Tong Soo KIM
The Korean Journal of Parasitology 2014;52(2):143-149
To evaluate the seroprevalence against circumsporozoite protein (CSP) of Plasmodium vivax in sera of Korean patients, the central repeating domain (CRD) of CSP was cloned and analyzed. From the genomic DNA of patient's blood, 2 kinds of CSPs were identified to belong to a VK210 type, which is the dominant repeating of GDRA(D/A)GQPA, and named as PvCSPA and PvCSPB. Recombinantly expressed his-tagged PvCSPA or PvCSPB in Escherichia coli reacted well against sera of patients in western blot, with the detecting rate of 47.9% (58/121), which included 15 cases positive for PvCSPA, 6 cases positive for PvCSPB, and 37 cases for both. The mixture of PvCSPA and PvCSPB was loaded to a rapid diagnostic test kit (RDT) and applied with the same set of patient sera, which resulted in detection rates of 57.0% (69/121). When the protein sequences of PvCSPA were compared with those of P. vivax in endemic regions of India and Uganda, they were compatibly homologous to PvCSPA with minor mutations. These results suggested that the recombinant PvCSPA and PvCSPB loaded RDT may be a milestone in latent diagnosis which has been a hot issue of domestic malaria and important for radical therapy in overlapped infections with P. falciparum in tropical and subtropical areas. During the biological process of malarial infection, exposure of CSP to antigen-antibody reaction up to 57.0% is the first report in Korea.
Amino Acid Sequence
;
Antibodies, Protozoan/*blood/immunology
;
Antibody Formation
;
Antigens, Protozoan/immunology
;
Base Sequence
;
Humans
;
India
;
Malaria, Vivax/*diagnosis/*epidemiology/immunology
;
Merozoite Surface Protein 1/genetics/*immunology
;
Plasmodium vivax/genetics/immunology
;
Protozoan Proteins/genetics/*immunology
;
Reagent Kits, Diagnostic
;
Recombinant Proteins/diagnostic use/immunology
;
Republic of Korea/epidemiology
;
Sequence Analysis, DNA
;
Seroepidemiologic Studies
;
Uganda
5.A Recombinant Plasmodium vivax Apical Membrane Antigen-1 to Detect Human Infection in Iran.
Afsaneh MOTEVALLI HAGHI ; Mohammad Reza KHORAMIZADE ; Mehdi NATEGHPOUR ; Mehdi MOHEBALI ; Gholam Hossein EDRISSIAN ; Mohammad Reza ESHRAGHIAN ; Zargham SEPEHRIZADEH
The Korean Journal of Parasitology 2012;50(1):15-21
In Iran, Plasmodium vivax is responsible for more than 80% of the infected cases of malaria per year. Control interventions for vivax malaria in humans rely mainly on developed diagnostic methods. Recombinant P. vivax apical membrane antigen-1 (rPvAMA-1) has been reported to achieve designing rapid, sensitive, and specific molecular diagnosis. This study aimed to perform isolation and expression of a rPvAMA-1, derived from Iranian patients residing in an endemic area. Then, the diagnostic efficiency of the characterized Iranian PvAMA-1 was assessed using an indirect ELISA method. For this purpose, a partial region of AMA-1 gene was amplified, cloned, and expressed in pET32a plasmid. The recombinant His-tagged protein was purified and used to coat the ELISA plate. Antibody detection was assessed by indirect ELISA using rPvAMA-1. The validity of the ELISA method for detection of anti-P. vivax antibodies in the field was compared to light microscopy on 84 confirmed P. vivax patients and compared to 84 non-P. vivax infected individuals. The ELISA cut-off value was calculated as the mean+2SD of OD values of the people living in malaria endemic areas from a south part of Iran. We found a cut-off point of OD=0.311 that showed the best correlation between the sera confirmed with P. vivax infection and healthy control sera. A sensitivity of 81.0% and specificity of 84.5% were found at this cut off titer. A good degree of statistical agreement was found between ELISA using rPvAMA-1 and light microscopy (0.827) by Kappa analysis.
Antibodies, Protozoan/blood/immunology
;
Antigens, Protozoan/*blood/genetics/immunology
;
Diagnostic Tests, Routine/*methods
;
Enzyme-Linked Immunosorbent Assay/*methods
;
Female
;
Humans
;
Iran
;
Malaria, Vivax/blood/*diagnosis/immunology/*parasitology
;
Male
;
Membrane Proteins/blood/genetics/immunology
;
Plasmodium vivax/isolation & purification/*physiology
;
Protozoan Proteins/blood/genetics/immunology
;
Sensitivity and Specificity
6.Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection.
Hyeong Woo LEE ; Sung Ung MOON ; Hye Sun RYU ; Yeon Joo KIM ; Shin Hyeong CHO ; Gyung Tae CHUNG ; Khin LIN ; Byoung Kuk NA ; Yoon KONG ; Kyung Suk CHUNG ; Tong Soo KIM
The Korean Journal of Parasitology 2006;44(1):49-54
In order to develop tools for an early serodiagnosis of Plasmodium falciparum infection, we evaluated the usefulness of P. falciparum liver stage antigen-3 (LSA-3) as a serodiagnostic antigen. A portion of LSA-3 gene was cloned, and its recombinant protein (rLSA-3) was expressed in Escherichia coli and purified by column chromatography. The purified rLSA-3 and 120 test blood/serum samples collected from inhabitants in malaria-endemic areas of Mandalay, Myanmar were used for this study. In microscopic examinations of blood samples, P. falciparum positive rate was 39.1% (47/120) in thin smear trials, and 33.3% (40/120) in thick smear trials. Although the positive rate associated with the rLSA-3 (30.8%) was lower than that of the blood stage antigens (70.8%), rLSA-3 based enzyme-linked immunosorbent assay could detect 12 seropositive cases (10.0%), in which blood stage antigens were not detected. These results indicate that the LSA-3 is a useful antigen for an early serodiagnosis of P. falciparum infection.
Recombinant Proteins/biosynthesis/genetics/*immunology
;
Plasmodium vivax/isolation & purification
;
Plasmodium falciparum/*immunology
;
Molecular Sequence Data
;
Malaria, Falciparum/blood/*diagnosis
;
Humans
;
Genes, Protozoan/genetics/immunology
;
Fluorescent Antibody Technique, Direct/methods
;
Escherichia coli/genetics
;
Enzyme-Linked Immunosorbent Assay/methods
;
Early Diagnosis
;
DNA, Protozoan/chemistry
;
DNA Primers/chemistry
;
Cloning, Molecular/methods
;
Base Sequence
;
Antigens, Protozoan/biosynthesis/chemistry/genetics/*immunology
;
Animals
;
Amino Acid Sequence
7.Efficacy of the Merozoite Surface Protein 1 of Plasmodium Vivax as an Antigen for ELISA to Diagnose Malaria.
Yong Man KIM ; Hyun Ah HWANG ; Woo Sang YUN ; Suk Il KIM ; Kil Whoan LEE ; Seung Kyu PARK ; Young Jin LEE ; Tae Kyun KIM ; Chansuda WONGSRICHANALAI ; Judy A SAKANARI ; Hyun PARK
Yonsei Medical Journal 2004;45(1):129-134
Malaria is still a major health problem in Thailand and its incidence is currently rising in Korea. To identify a useful antigen for the diagnosis of malaria patients, a cDNA expression library from malaria parasites was constructed and screened out immunologically. One clone was selected in view of its predominant reactivity with the patient sera. The recombinant malaria parasite antigen (Pv30) with 27 kDa as a C-terminal His-tag fusion protein that was produced in Escherichia coli was identified through immunoblot analysis. The deduced amino acid sequence had the sequence homology with the merozoite surface protein 1 (MSP1) genes of Plasmodium falciparum and P. yoelii, each by 41% and 42%, respectively. Measurement of serum IgG and IgM antibody to Pv30 by enzyme-linked immunosorbent assay (ELISA) was evaluated as a serodiagnostic test for malaria patients in Thailand (endemic area) and Korea (recently reemerging area). The sensitivity of P. vivax, P. falciparum, and P. malariae was 96.3% (26 /27), 90.6% (29/32), and 100% (6/6), respectively, and the specificity was 63.5% (40/63) in Thailand samples. The sensitivity of P. vivax was 98.8% (88/89), and the specificity was 96.6% (86/89) in Korean samples. Pv30 appears to be a good and reliable recombinant antigen for serodiagonosis of malaria in a nonendemic area.
Amino Acid Sequence
;
Animals
;
Antibodies, Protozoan
;
Enzyme-Linked Immunosorbent Assay/*methods
;
Human
;
Korea
;
Malaria, Vivax/*diagnosis/immunology
;
Merozoite Surface Protein 1/*analysis/genetics/immunology
;
Molecular Sequence Data
;
Plasmodium vivax/chemistry/immunology/*isolation & purification
;
Sensitivity and Specificity
;
Serologic Tests
;
Support, Non-U.S. Gov't
8.Evaluation of Rapid Diagnostics for Plasmodium falciparum and P. vivax in Mae Sot Malaria Endemic Area, Thailand.
Wanna CHAIJAROENKUL ; Thanee WONGCHAI ; Ronnatrai RUANGWEERAYUT ; Kesara NA-BANGCHANG
The Korean Journal of Parasitology 2011;49(1):33-38
Prompt and accurate diagnosis of malaria is the key to prevent disease morbidity and mortality. This study was carried out to evaluate diagnostic performance of 3 commercial rapid detection tests (RDTs), i.e., Malaria Antigen Pf/Pantrade mark, Malaria Ag-Pftrade mark, and Malaria Ag-Pvtrade mark tests, in comparison with the microscopic and PCR methods. A total of 460 blood samples microscopically positive for Plasmodium falciparum (211 samples), P. vivax (218), mixed with P. falciparum and P. vivax (30), or P. ovale (1), and 124 samples of healthy subjects or patients with other fever-related infections, were collected. The sensitivities of Malaria Ag-Pftrade mark and Malaria Antigen Pf/Pantrade mark compared with the microscopic method for P. falciparum or P. vivax detection were 97.6% and 99.0%, or 98.6% and 99.0%, respectively. The specificities of Malaria Ag-Pftrade mark, Malaria Ag-Pvtrade mark, and Malaria Antigen Pf/Pantrade mark were 93.3%, 98.8%, and 94.4%, respectively. The sensitivities of Malaria Ag-Pftrade mark, Malaria Antigen Pf/Pantrade mark, and microscopic method, when PCR was used as a reference method for P. falciparum or P. vivax detection were 91.8%, 100%, and 96.7%, or 91.9%, 92.6%, and 97.3%, respectively. The specificities of Malaria Ag-Pftrade mark, Malaria Ag-Pvtrade mark, Malaria Antigen Pf/Pantrade mark, and microscopic method were 66.2%, 92.7%, 73.9%, and 78.2%, respectively. Results indicated that the diagnostic performances of all the commercial RDTs are satisfactory for application to malaria diagnosis.
Antigens, Protozoan/blood
;
Cross-Sectional Studies
;
*Diagnostic Techniques and Procedures/instrumentation
;
Endemic Diseases/statistics & numerical data
;
Humans
;
Malaria/*diagnosis/epidemiology/parasitology
;
Malaria, Vivax
;
Plasmodium falciparum/genetics/immunology/*isolation & purification
;
Reagent Kits, Diagnostic
;
Thailand/epidemiology